The startup that wants to cure diseases and slow aging, with

Insilico Medicine was one of the first to merge AI with drug discovery. CEO Alex Zhavoronkov now says advances could help extend human life.

Related Keywords

San Francisco , California , United States , China , Shanghai , Alex Zhavoronkov , Fabio Urbina , Petrina Kamya , , Insilico Medicine , Google Owned Deepmind , Death Star , Life Star , Drug Candidates , Drug Discovery , Biotech Firm ,